Literature DB >> 12736879

Reliable serial measurement of cognitive processes in rehabilitation: the Cognitive Log.

Amy L Alderson1, Thomas A Novack.   

Abstract

OBJECTIVE: To evaluate the reliability and utility of a brief quantitative measure of cognitive recovery, the Cognitive Log (Cog-Log), developed for daily use with rehabilitation inpatients to provide information about the recovery of higher neurocognitive processes including verbal recall, attention, working memory, motor sequencing, and response inhibition.
DESIGN: Descriptive study of the Cog-Log's normative scores, reliability (interrater, internal consistency), and validity as shown by its relationship to standard neuropsychologic measures.
SETTING: Inpatient rehabilitation hospital affiliated with a large university medical center. PARTICIPANTS: One hundred fifty neurorehabilitation inpatients with acquired brain injury; 83 young adults without acquired brain injury were included to provide normative data.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: The Cog-Log; standardized neuropsychologic measures of memory (Wechsler Memory Scale-Revised, Rey Auditory Verbal Learning Test), language, attention (Wechsler Adult Intelligence Scale-Revised), and reasoning (Trail Making Test).
RESULTS: Reliability analysis showed strong interrater reliability across items (Spearman r, .749-1.00) and high internal consistency (Cronbach alpha=.778). Factor analysis of the Cog-Log using principal components extraction revealed a unitary factor (eigenvalue=3.48). Cog-Log items designed to measure working memory and immediate and delayed verbal memory were most strongly predictive of performance on similar standardized neuropsychologic measures administered on the same day.
CONCLUSION: The Cog-Log appears to be a reliable and efficient tool for measuring ongoing neurocognitive recovery during inpatient rehabilitation.

Entities:  

Mesh:

Year:  2003        PMID: 12736879     DOI: 10.1016/s0003-9993(02)04842-6

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  6 in total

1.  Months backward test: A review of its use in clinical studies.

Authors:  James Meagher; Maeve Leonard; Laura Donoghue; Niamh O'Regan; Suzanne Timmons; Chris Exton; Walter Cullen; Colum Dunne; Dimitrios Adamis; Alasdair J Maclullich; David Meagher
Journal:  World J Psychiatry       Date:  2015-09-22

2.  Predictors of driving avoidance and exposure following traumatic brain injury.

Authors:  Donald R Labbe; David E Vance; Virginia Wadley; Thomas A Novack
Journal:  J Head Trauma Rehabil       Date:  2014 Mar-Apr       Impact factor: 2.710

3.  'Stand still ... , and move on', a new early intervention service for cardiac arrest survivors and their caregivers: rationale and description of the intervention.

Authors:  Véronique Rmp Moulaert; Jeanine A Verbunt; Wilbert Gm Bakx; Anton Pm Gorgels; Marc Cftm de Krom; Peter Htg Heuts; Derick T Wade; Caroline M van Heugten
Journal:  Clin Rehabil       Date:  2011-05-12       Impact factor: 3.477

4.  'Stand still …, and move on' , an early neurologically-focused follow-up for cardiac arrest survivors and their caregivers: a process evaluation.

Authors:  Véronique R M Moulaert; Jolanda C M van Haastregt; Derick T Wade; Caroline M van Heugten; Jeanine A Verbunt
Journal:  BMC Health Serv Res       Date:  2014-01-23       Impact factor: 2.655

5.  Activity and Life After Survival of a Cardiac Arrest (ALASCA) and the effectiveness of an early intervention service: design of a randomised controlled trial.

Authors:  Véronique R M P Moulaert; Jeanine A Verbunt; Caroline M van Heugten; Wilbert G M Bakx; Anton P M Gorgels; Sebastiaan C A M Bekkers; Marc C F T M de Krom; Derick T Wade
Journal:  BMC Cardiovasc Disord       Date:  2007-08-27       Impact factor: 2.298

6.  Mental practice-based rehabilitation training to improve arm function and daily activity performance in stroke patients: a randomized clinical trial.

Authors:  Jeanine A Verbunt; Henk A M Seelen; Feljandro P Ramos; Bernard H M Michielsen; Wim L Wetzelaer; Martine Moennekens
Journal:  BMC Neurol       Date:  2008-04-11       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.